| Authors: |
Mitchell RE; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.; Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, BS8 2BN, United Kingdom., Hassan M; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.; Department of Pathology, Faculty of Medicine and Health Sciences, University Putra Malaysia, 43400, Serdang, Selangor, Malaysia., Burton BR; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Britton G; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.; Icahn School of Medicine at Mount Sinai, New York, USA., Hill EV; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Verhagen J; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.; Department of Immunobiology, King's College London School of Medicine, London, United Kingdom., Wraith DC; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom. d.wraith@bham.ac.uk.; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, United Kingdom. d.wraith@bham.ac.uk. |